Navigation Links
Novavax CEO to Present at the World Vaccine Congress 2008
Date:4/21/2008

ROCKVILLE, Md., April 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the World Vaccine Congress 2008 at 11:25 a.m. on April 23, 2008 in Washington D.C. Dr. Singhvi will provide an overview of the company's strategy, research and development progress.

Novavax has also been nominated as a Finalist for the Vaccine Industry Excellence (VIE) Awards 2008 in the 'Best Start Up' Category. The winner will be announced during the World Vaccine Congress Awards ceremony.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, highly potent, recombinant vaccines utilizing a new, efficient manufacturing solution.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
5. Avicena Group to Present at Noble Financial Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CEL-SCI to Present at the Noble Financial Conference
10. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mechanicsburg, Pa (PRWEB) May 20, 2013 ... controller with ramp/soak capabilities. The 5R6-900 benchtop controller ... enclosure, the device can be plugged into the wall ... own power supply. This distinctive detail makes the device ... , The laboratory temperature controller can also be ...
(Date:5/20/2013)...  (PSHR) Pacific Shore Holdings, Inc. a consumer ... broad range of product categories lines, today reports ... BlueWater Advisory Group, to provide strategic counsel and ... to direct the company,s outreach and investor awareness ... Matthew Mills , Pacific Shore Holdings, president ...
(Date:5/20/2013)... 20, 2013 With bed bugs' presence come ... although bed bugs need to be eliminated, one must make ... a person's health. And so to help bed bug sufferers ... get rid of bed bugs without using harmful pesticides. ... spray it called Bed Bug Bully. , According to My ...
(Date:5/20/2013)... --  Flexion Therapeutics , Inc. today announced the addition ... its management team as chief financial officer. Mr. Driscoll ... with biotechnology and medical device companies. Prior ... for Novavax (NASDAQ: NVAX ) where he ... through a combination of investment funding and commercial and ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Pacific Shore Holdings Retains Investor Relations Firm 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2
... RANCHO CORDOVA, Calif., Feb. 22 ThermoGenesis,Corp.(Nasdaq: KOOL ... recall of,certain lots of its AXP(TM) AutoXpress Platform(TM) (AXP) ... in a document review process that,some lots of the ... testing, which is a manufacturing release criterion., The ...
... Biopure Corporation,(Nasdaq: BPUR ) today announced its ... 2008. For the quarter, the company reported a net,loss ... with a net loss,of $6.9 million, or $0.53 per ... common shares outstanding on January 31, 2008 and 2007 ...
... grow over 5% annually over the next five ... years, according to Millennium Research Group, WALTHAM, Mass., Feb. ... 2008 report, the US market for,fixed C-arm systems, comprising units ... $1.4 billion in 2007 and will,rise to over $1.8 billion ...
Cached Biology Technology:ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets 2Biopure Announces 2008 First Quarter Financial Results 2Biopure Announces 2008 First Quarter Financial Results 3Biopure Announces 2008 First Quarter Financial Results 4Biopure Announces 2008 First Quarter Financial Results 5Biopure Announces 2008 First Quarter Financial Results 6Biopure Announces 2008 First Quarter Financial Results 7Fixed C-Arms Revolutionize Operating Room Environments 2
(Date:5/21/2013)... -- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today ... with Philips, industry leading Live 3D TEE, now offers ... available Live 3D TEE and ICE will be shown ... official meeting for the European Association of Percutaneous Cardiovascular ... in 2012, Philips CX50 xMATRIX has been the only ...
(Date:5/21/2013)... way genes function without changing the underlying DNA ... of pregnant women during any trimester, potentially providing ... weeks after giving birth, and an opportunity to ... of the small study involving 52 pregnant women ... Psychiatry . , "Postpartum depression can be harmful ...
(Date:5/20/2013)... resistant to the antibiotic colistin are also commonly ... body, according to a study in mBio ... Society for Microbiology. Cross-resistance to colistin and host ... body against bacterial attack, could mean that patients ... with a crippled immune response. Colistin is a ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... 2012  Medbox, Inc. (Pinksheets: MDBX) ( www.medboxinc.com ) ... new, highly secure, automated kiosk for the storage ... which uses biometric fingerprint recognition, safely stores medicines ... The system also provides a permanent record of ...
... German . Microscopes provide valuable insights in ... the latter remain in their natural environment. However, this ... Karlsruhe Institute of Technology (KIT), the Max Planck Institute ... of Health (NIH) have now developed a new method ...
... 16, 2012 Cardium Therapeutics (NYSE Amex: CXM) today ... of Gene & Cell Therapy (ASGCT) 15th Annual Meeting ... Center in Philadelphia, PA. The ... important role in adenovector gene transfection (delivery) in mammalian ...
Cached Biology News:Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctor's Offices. 2Nature: Microscope looks into cells of living fish 2Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial 2
...
... Mynox is the first ... by killing them, and not ... is the only anti-mycoplasma agent ... clean virus stocks directly. The ...
... can be used to label ... covalently bound acridinium NHS ester ... presence of hydrogen peroxide. Acridinium ... used as a detection method ...
... (EMSA) is a powerful tool for evaluating ... shift or gel retardation, the assay is ... to electrophoresis, free DNA will migrate differently ... Chemiluminescent EMSA Kit is a nonradioactive system ...
Biology Products: